soul trial oral semaglutide cardiovascular outcomes 2024 results mace Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 Cardiovascular Outcomes, Safety, and Tolerability

Description

Perspectives: The new lean: how weight loss drugs will affect Healthtech startups - Read the latest news and insights from Northzone, a multi-stage venture capital fund investing in startups from seed to growth.

Patients with prior cholecystectomy required higher doses of acarbose (p=0.046), compared to those without prior cholecystectomy

Beach enthusiast

Thirty-five years later, on April 26, 2019, the Kentucky Court of Appeals declared that law unconstitutional and effectively held that a lawyer must represent corporations and non-natural entities in []